Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol PR vs Morphine PR in Children with Chronic Pain
NCT02151682Phase 3Completed
- Sponsor
- Grünenthal GmbH
- Start
- Apr 2015
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 3 trial of tapentadol in pain, sponsored by Grünenthal GmbH. Started Apr 2015; status: completed.
02
Drugs
tapentadol
03
Conditions
pain
Beyond the preview
Go deeper on NCT02151682.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151682.